350 related articles for article (PubMed ID: 29548911)
1. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
[TBL] [Abstract][Full Text] [Related]
2. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
[TBL] [Abstract][Full Text] [Related]
4. Probable mechanisms involved in the antipsychotic-like activity of morin in mice.
Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Owoeye O; Olonode ET; Iwalewa EO
Biomed Pharmacother; 2018 Sep; 105():1079-1090. PubMed ID: 30021344
[TBL] [Abstract][Full Text] [Related]
5. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
[TBL] [Abstract][Full Text] [Related]
6. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia.
Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Omogbiya IA; Owoeye O; Umukoro S; Iwalewa EO
Int Immunopharmacol; 2019 May; 70():338-353. PubMed ID: 30852289
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice.
Oshodi TO; Ben-Azu B; Ishola IO; Ajayi AM; Emokpae O; Umukoro S
Mol Biol Rep; 2021 Mar; 48(3):2335-2350. PubMed ID: 33811574
[TBL] [Abstract][Full Text] [Related]
8. Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.
Ben-Azu B; Uruaka CI; Ajayi AM; Jarikre TA; Nwangwa KE; Chilaka KC; Chijioke BS; Omonyeme MG; Ozege CB; Ofili EC; Warekoromor EB; Edigbue NL; Esiekpe UV; Akaenyi DE; Agu GO
Neurochem Res; 2023 Mar; 48(3):816-829. PubMed ID: 36350433
[TBL] [Abstract][Full Text] [Related]
9. Repeated psychosocial stress causes glutamic acid decarboxylase isoform-67, oxidative-Nox-2 changes and neuroinflammation in mice: Prevention by treatment with a neuroactive flavonoid, morin.
Ben-Azu B; Emokpae O; Ajayi AM; Jarikre TA; Orhode V; Aderibigbe AO; Umukoro S; Iwalewa EO
Brain Res; 2020 Oct; 1744():146917. PubMed ID: 32474018
[TBL] [Abstract][Full Text] [Related]
10. Morin Pretreatment Attenuates Schizophrenia-Like Behaviors in Experimental Animal Models.
Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Iwalewa EO
Drug Res (Stuttg); 2018 Mar; 68(3):159-167. PubMed ID: 28962045
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine.
Valvassori SS; da Rosa RT; Dal-Pont GC; Varela RB; Mastella GA; Daminelli T; Fries GR; Quevedo J; Zugno AI
Int J Dev Neurosci; 2023 Dec; 83(8):691-702. PubMed ID: 37635268
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
Zugno AI; Chipindo HL; Volpato AM; Budni J; Steckert AV; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Mastella GA; Maravai SG; Wessler PG; Binatti AR; Panizzutti B; Schuck PF; Quevedo J; Gama CS
Neuroscience; 2014 Feb; 259():223-31. PubMed ID: 24316471
[TBL] [Abstract][Full Text] [Related]
13. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
Gama CS; Canever L; Panizzutti B; Gubert C; Stertz L; Massuda R; Pedrini M; de Lucena DF; Luca RD; Fraga DB; Heylmann AS; Deroza PF; Zugno AI
Schizophr Res; 2012 Nov; 141(2-3):162-7. PubMed ID: 22954755
[TBL] [Abstract][Full Text] [Related]
14. Combinational effects of ketamine and amphetamine on behaviors and neurotransmitter systems of mice.
Lai CC; Lee LJ; Yin HS
Neurotoxicology; 2013 Jul; 37():136-43. PubMed ID: 23660488
[TBL] [Abstract][Full Text] [Related]
15. Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
Monte AS; de Souza GC; McIntyre RS; Soczynska JK; dos Santos JV; Cordeiro RC; Ribeiro BM; de Lucena DF; Vasconcelos SM; de Sousa FC; Carvalho AF; Macêdo DS
J Psychopharmacol; 2013 Nov; 27(11):1032-43. PubMed ID: 24045882
[TBL] [Abstract][Full Text] [Related]
16. Ketamine administration induces early and persistent neurochemical imbalance and altered NADPH oxidase in mice.
Schiavone S; Morgese MG; Bove M; Colia AL; Maffione AB; Tucci P; Trabace L; Cuomo V
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109750. PubMed ID: 31446158
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice.
Ben-Azu B; Aderibigbe AO; Ajayi AM; Iwalewa EO
Pharm Biol; 2016 Dec; 54(12):2871-2879. PubMed ID: 27250524
[TBL] [Abstract][Full Text] [Related]
18. Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.
da Silva Araújo T; Maia Chaves Filho AJ; Monte AS; Isabelle de Góis Queiroz A; Cordeiro RC; de Jesus Souza Machado M; de Freitas Lima R; Freitas de Lucena D; Maes M; Macêdo D
J Psychiatr Res; 2017 Jan; 84():49-58. PubMed ID: 27697587
[TBL] [Abstract][Full Text] [Related]
19. Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.
Brum GF; Rosa HZ; Rossato DR; Rosa JLO; Metz VG; Milanesi LH; Burger ME
Neurotox Res; 2020 Aug; 38(2):274-286. PubMed ID: 32458406
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration.
Angelucci F; Mathé AA; Aloe L
J Neurosci Res; 2000 Jun; 60(6):783-94. PubMed ID: 10861791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
